PLATEAU STATE DRUGS AND MEDICAL COMMODITIES MANAGEMENT AGENCY - DMCMA

29/01/2026

National Product Supply Chain Management Programme Conducts Maturity Assessment on PS–DMCMA

The National Product Supply Chain Management Programme has successfully carried out SHSS/ DMA maturity assessment on the Pharmaceutical Services Department of the Plateau State Drugs and Medical Commodities Management Agency (PS–DMCMA).

The assessment was conducted to evaluate the effectiveness, efficiency, and robustness of the agency’s supply chain management processes.

The assessment team was formally received by the Director General of PS–DMCMA, Pharm. Kim Jerry Bot, alongside the management team of the agency. In his welcome address, the Director General expressed appreciation, first of all to His Excellency, Barr Caleb M. Mutfwang, Executive Governor of Plateau State for the support the Agency is enjoying from the robust healthcare delivery package of the administration, and then to the assessment team for the visit and acknowledged the presence and continued support of health partners who have contributed significantly to the success of the DMA.

During the exercise, Pharm. Kim Jerry Bot delivered a comprehensive presentation highlighting the operations of the agency. The presentation covered the mission, vision, core mandate, organizational growth, achievements, future aspirations, and key challenges faced by the agency.

He concluded by expressing optimism that the maturity assessment would provide valuable insights, open doors to new opportunities, and support continuous improvement and sustainable growth within the agency.

Speaking during the programme, the Team Lead of the National Product Supply Chain Management Programme, pharm. Bashir Yusuf- consultant National Product Supply Chain Management Program (NPSCMP) commended the agency for the detailed presentation, noting that most of the assessment requirements were clearly demonstrated and aligned with the presentation delivered.

He explained that the assessment would focus on critical areas including the governance structure, strategic frameworks, and Drug Revolving Fund (DRF) management of the DMA.

He further outlined the key objectives of the maturity assessment, which include establishing a performance baseline, identifying system bottlenecks and capacity gaps, developing actionable improvement roadmaps, strengthening accountability and transparency, and enhancing data-driven decision-making and coordination with partners.

The assessment was in three phases; the presentation and examination section, physical assessment and the evaluation.

Representative of Africa Resource Centre For Excellence in Supply Chain Management (ARC- ESM), George Chima led the physical assessment of the warehouse alongside the Director General, Directors and pharmacist, ensuring that the physical assessment is in line with the standard.

The maturity assessment marks an important step towards strengthening supply chain systems and improving service delivery within PS–DMCMA.

24/01/2026

BPHARM NIG. LTD DONATES DELIVERY AND LOGISTICS VANS TO DRUGS MANAGEMENT AGENCY

Bochepharm Nigeria Limited has reinforced its commitment to strengthening healthcare delivery in the state with the donation of two (2) delivery and logistics vans to the Plateau State Drugs and Medical Commodities Management Agency (PS-DMCMA).

The donation, aimed at enhancing the agency’s logistics and distribution capacity, underscores Bpharm’s continued partnership and support for the PS-DMCMA in ensuring timely and efficient delivery of essential medicines to health facilities across the state.

Speaking during the presentation, the Regional Manager of Bpharm Nigeria Limited, Mr. Victor Obi stated that the gesture was part of the company’s deliberate effort to support the logistics arm of the agency, which plays a critical role in drug distribution. He noted that improving delivery timelines would ultimately enhance healthcare outcomes for residents of the state.

Mr. Obi expressed appreciation to the agency for the confidence reposed in Bpharm and its products, describing the partnership as one built on trust and shared goals. He further expressed optimism for a long-term and mutually beneficial partnership with the agency.

Receiving the vehicles on behalf of the agency, Director-General of the agency, Pharm. Kim Jerry Bot expressed profound gratitude to Bpharm Nigeria Limited for its responsiveness and sensitivity to the agency’s needs. He noted that the donation came at a critical time, as logistics and delivery of medical commodities to health facilities had been one of the agency’s major challenges.

According to him, the addition of the delivery vans will significantly enhance the agency’s logistics operations, improve mobility, and strengthen healthcare service delivery across the state.

Pharm. Bot commended Bpharm Nigeria Limited as one of the agency’s most reliable partners, describing the donation as a major milestone that would contribute to the growth and efficiency of the PS-DMCMA. He also called on other pharmaceutical companies to emulate Bpharm’s example by engaging in profitable partnerships that would further strengthen the agency’s operations.

He highlighted Maluther as one of the agency’s preferred anti-malaria drugs in the state, reaffirming the strong working relationship between PS-DMCMA and Bpharm Nigeria Limited.

22/01/2026

Malaria Consortium Visits PS-DMCMA, LMCU

Malaria Consortium has paid a courtesy visit to the Plateau State Drugs and Medical Commodities Management Agency (PS-DMCMA) and the Logistics Management Coordination Unit (LMCU) to appreciate their unwavering support and commitment to the successful implementation of malaria programmes through 2025.

Speaking during the visit, the Team Lead and State Programme Manager of Malaria Consortium, Dr. Mbwas Mashor, expressed gratitude to PS-DMCMA and the Logistics Management Coordination Unit, and the Director-General for their strong cooperation and support, which contributed to the successful implementation of activities in the previous year. He emphasized the importance of sustained partnership and collaboration, particularly in ensuring the safe delivery, proper storage, and effective warehousing of malaria commodities.

In his response, the Director-General of PS-DMCMA, Pharm Kim Jerry Bot, appreciated the Malaria Consortium team for the visit and commended their dedication to improving healthcare delivery in the state. He noted that warehousing of medical commodities goes beyond routine duty, describing it as a service to the people, adding that one of the key priorities of the The Time is Now Administration of His Excellency, Barr Caleb Manasseh Mutfwang, is to ensure a healthy population.

Pharm Kim assured the team that the Agency would continue to provide safe and secure warehousing for their commodities and support the distribution process through to the final delivery points. He reiterated the Agency’s commitment to closely monitoring all warehouse activities to ensure efficiency and accountability.

The Director-General welcomed continued collaboration and expressed optimism about sustaining the partnership throughout the year. He affirmed the Agency’s readiness to partner with Malaria Consortium to achieve optimal results and called for improved planning and coordination. He also requested the inclusion of PS-DMCMA in trainings, engagements, and related activities that would align with, and strengthen their joint efforts.

Earlier, the Logistics Management Coordination Unit (LMCU) Coordinator, Pharm Joshua Davuruk expressed appreciation to Malaria Consortium for the courtesy visit and for their continued collaboration with the state. He emphasized that effective logistics coordination is central to achieving improved healthcare outcomes, particularly in malaria prevention and control.

He reaffirmed the commitment of the LMCU to ensuring efficient, transparent, and timely management of health commodities across the state, noting that strong partnerships with implementing partners such as Malaria Consortium have strengthened the supply chain system.

Davuruk expressed optimism that sustained collaboration, improved planning, and shared accountability would further enhance programme implementation and service delivery at all levels.

The PS-DMCMA DG concluded by encouraging the Malaria Consortium team to sustain their commendable work, noting that their interventions are gradually reducing the burden of malaria in Plateau State.

20/01/2026

PS-DMCMA Conducts Training on Immunoassay and HB Meta Analysers

The Plateau State Drugs and Medical Commodities Management Agency (PS-DMCMA) has organized a training programme for laboratory scientists on the use of Immunoassay Analysers and HB Mate (PCV and HB) Analysers to strengthen diagnostic services in health facilities across the state.

Declaring the training open, the Director General, Pharmacist Kim Jerry Bot, welcomed participants and emphasized the importance of continuous capacity building to improve healthcare delivery. He appreciated the Executive Governor of Plateau State, His Excellency, Barr. Caleb Manasseh Mutfwang, for his unwavering commitment and support to the health sector for the benefit of Plateau citizens.

Pharmacist Bot also commended the Director of Laboratory Services, Plateau State Hospital Management Board, Mr. Dimlong Moses, for his support and collaboration. In his remarks, Mr. Dimlong appreciated the PS-DMCMA management for organizing the training and reaffirmed his commitment to strengthening laboratory services in the state.

The Director General highlighted diagnostic challenges at secondary healthcare facilities and stressed the need to optimize the use of GeneXpert machines for effective viral load testing.

The facilitator, Mr. Henry from Codix Pharma Nigeria Limited, explained the operation of the analysers, noting that they can run multiple tests simultaneously, thereby improving efficiency and turnaround time in laboratories.

15/01/2026

Sustaining Access to Essential Medicines and Commodities

Staff of the Plateau State Drugs and Medical Commodities Management Agency (PS-DMCMA) are carrying on with the distribution exercise of essential medicines and medical supplies which is designed to strengthen the supply chain system, ensuring that drugs reach health facilities without delay.

These is part of a broader strategy to improve healthcare delivery across the state, with a focus on rural communities that often face challenges in accessing medical commodities.

It is to be noted that the Agency is committed to transparency and accountability in the management of medical supplies.

The communities for the distribution of this commodities includes, Pankshin, Mangu, Bokkos, Kanke, Barkin Ladi, Jos East, Jos South, Jos North, Riyom and Bassa.

The Executive Governor of Plateau State, His Excellency, Barr Caleb Manasseh Mutfwang has reiterated his administration’s resolve to prioritize healthcare. This distribution is a critical step toward building a healthier Plateau.

15/01/2026

PS-DMCMA Holds End-of-Year Get-Together

The Plateau State Drugs and Medical Commodities Management Agency (PS-DMCMA) has successfully hosted its End-of-Year Get-Together and Send-Off Ceremony at the Agency’s Conference Hall.

Originally scheduled for December 2025, the event was postponed due to unforeseen circumstances. In line with the saying, “Better late than never,” the gathering eventually took place, bringing together the Director General, Management, and staff of the Agency in an atmosphere of fellowship, appreciation, and celebration.

The occasion also featured a special send-off prayer session in honour of two staff members, Pharm Joel Dalok, former Director, Warehousing and Logistics, and Mrs Abigail Gofwan, former Confidential Secretary to the Director General, who retired from active service recently.

In his opening address, the Director General, Pharm. Kim Jerry Bot, expressed profound gratitude to the management and staff for their unwavering dedication and contributions to the growth of the Agency and the promotion of quality healthcare delivery in Plateau State.

He encouraged staff to remain steadfast in their duties, uphold professionalism, and continue striving for excellence. He also apologized for the delay in hosting the event as originally planned, while thanking God for the opportunity to celebrate at this time.

Pharm. Kim paid glowing tribute to the former Confidential Secretary, Mrs. Abigail Gofwan, describing her as a dependable and exemplary subordinate whose loyalty and selfless service greatly benefited the Agency and the State. As a mark of appreciation, gifts were presented to her on behalf of the Agency.

In her remarks, Mrs. Gofwan expressed heartfelt gratitude to God for the grace to complete her years of service successfully. She thanked the Director General, management, and staff for the honour accorded her, and urged colleagues to remain diligent, faithful, and committed in their duties.

In another vein, the Director of Administration, Mrs. Salamatu Parlong, commended the Director General and management for organizing such a memorable event. She praised staff for their teamwork and encouraged continued cooperation and unity to enhance productivity.

Other Directors also spoke, before the Staff Officer also addressed the gathering, reminding staff to carry out their responsibilities with diligence, accountability, and reverence before God.

The ceremony ended on a cheerful note, with laughter, jokes, and heartfelt expressions of love and fellowship. Refreshments were served to all attendees, rounding off the event as a truly memorable occasion for the Agency.

12/01/2026

PS-DMCMA Donates Laboratory Equipment to HMB.


The Plateau State Drugs and Medical Commodities Management Agency (PS-DMCMA) has donated two laboratory machines to the Plateau State Hospital Management Board (PSHMB) as part of its renewed commitment to strengthening healthcare delivery through strategic partnerships and corporate social responsibility initiatives.

The donation, which includes a microscope and a Fluorescent Immunology Analyzer was presented by the Director-General of PS-DMCMA, Pharm. Kim Jerry Bot, at the office of the Chief Medical Director (CMD) of the Plateau State Hospital Management Board.
The gesture underscores the agency’s 2026 mandate to reinvigorate collaborations with key stakeholders in the health sector.

Speaking during the presentation, Pharm. Kim Jerry Bot stated that the donation aligns with the healthcare reform agenda of the Executive Governor of Plateau State, His Excellency Barr. Caleb Manasseh Mutfwang, who has consistently emphasized the need for accessible, efficient, and quality healthcare services for all citizens of the state.

He noted that the Governor’s people-centred leadership and commitment to strengthening public health institutions have continued to inspire agencies under his administration to pursue impactful collaborations and interventions. According to him, the donation reflects PS-DMCMA’s support for the Governor’s vision of a responsive and resilient healthcare system.
Pharm. Kim emphasized the importance of optimal utilization and proper maintenance of the equipment to enhance diagnostic capacity, improve service delivery, and ultimately contribute to better health outcomes for the people of Plateau State.

In his response, the Chief Medical Director of PSHMB, Dr Sumi Benjamin Garkuwa, expressed deep appreciation to the Director-General and the management of PS-DMCMA for their proactive support. He noted that the laboratory equipment was donated at a critical time and would significantly aid laboratory scientists in delivering quality services.

The CMD reaffirmed the Hospital Management Board’s commitment to excellence in healthcare delivery and pledged continued support for PS-DMCMA’s initiatives.

He added that a vibrant and effective PS-DMCMA would contribute immensely to the growth of the healthcare sector in Plateau State.
He further offered prayers for strength, success, and continued progress for the Director-General, his management team, and the Plateau State Government.

30/12/2025

DG, PS-DMCMA Leads NTBLCP(GF) & NPSCMP in Inspection of Warehouse II Renovation

The Director General of the Plateau State Drugs and Medical Commodities Management Agency (PS-DMCMA) Pharm. Kim Jerry Bot has led a joint inspection team from the National Tuberculosis, Leprosy and Buruli Ulcer Control Programme (NTBLCP) and the National Product Supply Chain Management Programme (NPSCMP) to review the ongoing renovation works at Warehouse II, alongside additional infrastructural upgrades at the agency’s PharmaGrade warehouse.

The inspection visit, was aimed at assessing the progress of the renovation project and ensuring that the facility meets standards for medical commodities storage and distribution.
The DG emphasized that the renovation of Warehouse II is a critical step in strengthening Plateau State’s capacity to manage essential drugs and medical supplies efficiently.
Pharm Jerry Bot commended the executive governor of plateau state, His excellency, Barr. Caleb Manasseh Mutfwang for his visionary leadership and commitment to transparency, accountability and improved health care delivery.
He noted that the governor support has created an enabling environment that allows PS- DMCMA to operate efficiently and in line with global best practices.

Representatives of NTBLCP and NPSCMP commended the Plateau State Government for prioritizing health infrastructure. They noted that the upgraded warehouse will enhance the safe storage of tuberculosis medicines, vaccines, and other essential commodities, thereby improving supply chain management and reducing stock-out risks across the state.

The renovation project includes structural improvements, installation of modern shelving systems, climate control measures, and enhanced security features. Additional works are also being carried out to expand office spaces and improve staff working conditions.

With the inspection completed, stakeholders expressed confidence that the renovated Warehouse II will soon be commissioned, marking a significant milestone in Plateau State’s healthcare delivery system.

25/12/2025

24/12/2025

PCN Conducts Regulatory Inspection of PSDMCMA

The Pharmacy Council of Nigeria (PCN), a Federal Government regulatory agency responsible for regulating and controlling pharmacy education, training, and practice in Nigeria, has conducted an inspection visit to the Plateau State Drugs and Medical Commodities Management Agency (DMA).

The inspection was carried out as part of the Council’s statutory mandate to inspect, approve, register, and license pharmaceutical activities across the country, including manufacturing, importation, warehousing, distribution, wholesale and retail pharmacy practice, as well as Patent and Proprietary Medicine Vendor (PPMV) operations.

The visit focused on inspecting, approving, and registering the warehousing and distribution operations of the Plateau State Drugs and Medical Commodities Management Agency, in line with the National Drug Distribution Guidelines. As a pharmaceutical agency engaged in the warehousing and distribution of drugs and medical commodities, the DMA is required to undergo periodic inspections by the PCN to ensure compliance with established regulatory standards, guidelines, and laws governing pharmaceutical practice in Nigeria.

The PCN inspection team was formally received by the Director General of the Plateau State Drugs and Medical Commodities Management Agency, Pharm. Kim Jerry Bot and it's management, who warmly welcomed the team and expressed appreciation to the Pharmacy Council of Nigeria for finding time to conduct the inspection visit.

In his remarks, the Director General acknowledged the support and commitment of the Plateau State Government under the leadership of His Excellency, Governor Caleb Manasseh Mutfwang, towards strengthening the state’s health sector. He noted that the Governor’s administration has continued to prioritize access to quality, safe, and affordable medicines through sustained investment in healthcare infrastructure, policy support, and institutional reforms. According to him, the progress recorded by the agency is largely attributable to the Governor’s vision for an efficient and accountable drug management system in Plateau State.

During the visit, the Director General delivered a comprehensive presentation providing an overview of the agency. The presentation highlighted the mandate and functions of the agency, its organizational structure, key achievements and successes recorded over time, as well as challenges encountered in the discharge of its responsibilities. This presentation enabled the inspection team to gain a clear understanding of the agency’s operations, management framework, and overall performance.

The inspection visit by the Pharmacy Council of Nigeria underscores the critical role of regulatory oversight in ensuring safe, effective, and well-coordinated pharmaceutical warehousing and distribution systems in Nigeria. The participation of the Plateau State Drugs and Medical Commodities Management Agency in the inspection process further demonstrates its commitment to compliance with national pharmaceutical regulations and adherence to best practices, in line with the health sector reforms of the Plateau State Government.

19/12/2025

Stakeholder Sensitization Engagement on State DRF Operationalization; Day 4

The ongoing Stakeholder Sensitization Engagement on the operationalization of the State Drug Revolving Fund (DRF) ended its fourth day on a high, marking another important step in the collective effort to strengthen access to quality medicines across the state. With the theme “Strengthening Access to Quality Medicines Through an Efficient Drug Revolving Fund System,” the engagement continues to draw participation from key actors across the health sector.

Addressing participants, Pharm Kim Jerry Bot, Director General, Plateau State Drugs and Medical Commodities Management Agency (PS-DMCMA) emphasized the critical role stakeholders play in ensuring effective service delivery.
He noted that the weeklong activity was deliberately designed to allow for deeper interaction, shared learning, and honest conversations about the challenges and opportunities within the state’s drug supply system.

“It is a very good thing to have you here today,” Pharm Kim reiterated, acknowledging the long-standing collaboration with many of the attendees. Participants were encouraged participants to freely engage, ask questions, and contribute their experiences, stressing that essential medicines remain central to healthcare practice and must be managed with diligence, transparency, and efficiency.

The DG highlighted that the state has made significant progress in strengthening its health systems, but more work remains. “We have been doing this work together. Now is the time to fortify and do it better,” he noted, calling for renewed commitment from all stakeholders involved in procurement, distribution, facility management, and service delivery.

The engagement also underscored the administration’s dedication to improving healthcare outcomes. Participants were reminded of the mandate of His Excellency, Barr. Caleb Manasseh Mutfwang, whose vision for the health sector places strong emphasis on accountability, availability of essential drugs, and sustainable systems that serve the people effectively.
Participants were reminded that the responsibility rests on everyone within the health value chain. “The task is on all of us. Unless we work together, the goals we seek will remain out of reach,” the DG emphasized.

In response to the challenges identified during the training period, several key measures were implemented to address them. To ensure effective and timely last-mile delivery of drugs and medical commodities to health facilities, a tracking motorcycle will be provided to the essential drug officer or logistician in each Local Government Area (LGA).
In addition, tablets (digital devices) will be supplied to support accurate, efficient, and user-friendly documentation.

The Ward Development Committees (WDCs) were also actively engaged in the training. As a core component of the Drug Revolving Fund (DRF) system, WDCs play a critical role in community sensitization and in supporting effective and sustainable healthcare delivery.

As the sensitization continues, stakeholders remain optimistic that the revitalized Drug Revolving Fund system will not only improve access to quality medicines but also restore public confidence in healthcare facilities across the state.

17/12/2025

Health Commissioner Calls for Effective Operationalization of DRF

The Plateau State Commissioner for Health, Dr. Nicholas Baamlong, has called on health stakeholders to ensure the effective operationalization of the State Drug Revolving Fund (DRF) in order to strengthen healthcare service delivery across the state.

Dr. Baamlong made this call while addressing participants at the week long stakeholders’ sensitization and engagement meeting on the operationalization of the DRF, held at the conference hall of the Plateau State Drugs and Medical Commodities Management Agency (PS-DMCMA).

The Commissioner commended the PS-DMCMA, describing it as timely and necessary for addressing identified gaps in operational knowledge, management of the Drug Management Agency (DMA), and concerns raised by health workers. He noted that the training was aimed at improving understanding, enhancing efficiency, and ensuring the smooth operation of the DRF across the state.

He urged participants to remain attentive, actively participate in discussions, and share the knowledge gained with colleagues at their respective duty posts, stressing that this would contribute to a more efficient and sustainable healthcare system.

Dr. Baamlong expressed optimism that a properly functioning DMA would significantly improve access to quality healthcare services for residents of Plateau State.

Earlier, the Director-General of the Plateau State Drugs and Medical Commodities Management Agency, Pharm. Kim Jerry Bot, appreciated participants for their commitment and encouraged open and frank discussions. He stated that the engagement was designed to be interactive, allowing participants to share challenges and make meaningful contributions toward achieving effective healthcare delivery and the optimal operation of the Drug Revolving Fund in the state.